Shopping Cart
- Remove All
- Your shopping cart is currently empty
Teprasiran (QPI-1002) is an RNA-based compound that transiently suppresses p53-dependent apoptosis, a process involved in the development of acute kidney injury (AKI).
Pack Size | Price | Availability | Quantity |
---|---|---|---|
5 mg | Inquiry | Backorder |
Description | Teprasiran (QPI-1002) is an RNA-based compound that transiently suppresses p53-dependent apoptosis, a process involved in the development of acute kidney injury (AKI). |
In vitro | Teprasiran is a synthetic, chemically stabilized small interfering RNA (siRNA) that induces RNA interference to transiently suppress p53 expression for approximately 48 to 72 hours[1]. |
Alias | QPI-1002 |
Cas No. | 1231737-88-4 |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.